The World of Health & Medicine News

US court blocks most Trump tariffs, says president exceeded his authority

US court blocks most Trump tariffs, says president exceeded his authority

A U.S. trade court blocked President Donald Trump’s tariffs from going into effect in a sweeping ruling on Wednesday that found the president overstepped his authority by imposing across-the-board duties on imports from U.S. trading partners.

The Court of International Trade said the U.S. Constitution gives Congress exclusive authority to regulate commerce with other countries that is not overridden by the president’s emergency powers to safeguard the U.S. economy.

“The court does not pass upon the wisdom or likely effectiveness of the President’s use of tariffs as leverage,” a three-judge panel said in the decision to issue a permanent injunction on the blanket tariff orders issued by Trump since January. “That use is impermissible not because it is unwise or ineffective, but because [federal law] does not allow it.”

The judges also ordered the Trump administration to issue new orders reflecting the permanent injunction within 10 days. The Trump administration minutes later filed a notice of appeal and questioned the authority of the court.

The court invalidated with immediate effect all of Trump’s orders on tariffs since January that were rooted in the International Emergency Economic Powers Act (IEEPA), a law meant to address “unusual and extraordinary” threats during a national emergency.

The court was not asked to address some industry-specific tariffs Trump has issued on automobiles, steel and aluminum, using a different statute.

The decisions of the Manhattan-based Court of International Trade, which hears disputes involving international trade and customs laws, can be appealed to the U.S. Court of Appeals for the Federal Circuit in Washington, D.C., and ultimately the U.S. Supreme Court.

spot_img

Explore more

spot_img

GSK, Spero stop UTI drug trial after early success

GSK, Spero stop UTI drug trial after early success GSK plans to seek approval of a new antibiotic for complicated urinary tract infections after...

New robot helps old people with frailty to walk without fear...

New robot helps old people with frailty to walk without fear of falls Getting on in years means not being as light on one's feet...

Pfizer-Arvinas breast cancer drug tops AstraZeneca’s in delaying progression

Pfizer-Arvinas breast cancer drug tops AstraZeneca's in delaying progression An experimental treatment by Pfizer (PFE.N), opens new tab and Arvinas (ARVN.O), opens new tab delayed progression of breast cancer...

China approves first domestically produced nine-valent HPV vaccine

China approves first domestically produced nine-valent HPV vaccine China approved its first domestically developed nine-valent human papillomavirus (HPV) vaccine on Thursday, according to the National...

5 ways smoking causes damage beyond lungs and heart, and issues...

5 ways smoking causes damage beyond lungs and heart, and issues from herpes to infertility Are you a smoker – or does someone you love...

Amgen blood platelet booster helps patients who need chemotherapy

Amgen blood platelet booster helps patients who need chemotherapy Ahead of the American Society of Clinical Oncology (ASCO) meeting, researchers reported that Amgen’s Nplate, a...

Gilead’s Trodelvy, with Keytruda, cuts breast cancer risk by 35% in...

Gilead's Trodelvy, with Keytruda, cuts breast cancer risk by 35% in trial Gilead Sciences' (GILD.O), opens new tab Trodelvy in combination with Merck's (MRK.N), opens new tab blockbuster immunotherapy...

Gilead commits to HIV prevention rollout for low-income countries despite funding...

Gilead commits to HIV prevention rollout for low-income countries despite funding uncertainty Gilead Sciences says it still plans to supply its twice-yearly injection for preventing...